A new day dawns: women without oestrogen or is a balance best?

Por Jordan, V Craig
Publicado em 2002

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

Por Jordan, V Craig
Publicado em 2006

Tamoxifen: catalyst for the change to targeted therapy

Por Jordan, V. Craig
Publicado em 2008

New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer

Por Jordan, V. Craig
Publicado em 2007

Tamoxifen as the First Targeted Long Term Adjuvant Therapy for Breast Cancer

Por Jordan, V. Craig
Publicado em 2014

A(nother) scientific strategy to prevent breast cancer in post-menopausal women by enhancing estrogen-induced apoptosis?

Por Jordan, V. Craig
Publicado em 2014

Linking Estrogen-Induced Apoptosis With Decreases in Mortality Following Long-term Adjuvant Tamoxifen Therapy

Por Jordan, V. Craig
Publicado no J Natl Cancer Inst (2014)

Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale

Por Jordan, V Craig
Publicado no Br J Clin Pharmacol (2015)

The New Biology of Estrogen-induced Apoptosis Applied to Treat and Prevent Breast Cancer

Por Jordan, V Craig
Publicado no Endocr Relat Cancer (2014)

Avoiding the Bad and Enhancing the Good of Soy Supplements in Breast Cancer

Por Jordan, V. Craig
Publicado no J Natl Cancer Inst (2014)

A Raloxifene Withdrawal Response: Translational Research, Definitions, and Clinical Applications

Por Jordan, V. Craig
Publicado no Integr Cancer Ther (2016)

The 4Ps of Breast Cancer Chemoprevention: Putting Proven Principles into Practice

Por Jordan, V. Craig
Publicado no Cancer Prev Res (Phila) (2017)

Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive

Por Jordan, V. Craig
Publicado no Clin Cancer Res (2018)

Raloxifene as a multifunctional medicine? : Current trials will show whether it is effective in both osteoporosis and breast cancer 

Por Jordan, V Craig, Morrow, M
Publicado em 1999

Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells

Por Peng, Jing, Jordan, V. Craig
Publicado em 2010

Progress in endocrine approaches to the treatment and prevention of breast cancer

Por Obiorah, Ifeyinwa, Jordan, V. Craig
Publicado em 2011

2012 Nams/Pfizer- Wulf H. Utian Endowed Lecture The scientific rationale for a delay after menopause in the use of conjugated equine estrogens in postmenopausal women that causes a...

Por Obiorah, Ifeyinwa, Jordan, V. Craig
Publicado em 2013

Acquired Resistance to Selective Estrogen Receptor Modulators (SERMs) in Clinical Practice (Tamoxifen & Raloxifene) by Selection Pressure in Breast Cancer Cell Populations

Por Fan, Ping, Jordan, V. Craig
Publicado em 2014

How PERK kinase conveys stress signals to nuclear factor-κB to mediate estrogen-induced apoptosis in breast cancer cells?

Por Fan, Ping, Jordan, V. Craig
Publicado no Cell Death Dis (2018)

The Modulation of Estrogen-Induced Apoptosis as an Interpretation of the Women’s Health Initiative Trials

Por Jordan, V Craig, Abderrahman, Balkees
Publicado no Expert Rev Endocrinol Metab (2015)